As a Ryman Healthcare shareholder, you may have been pleased to see the company recently report an underlying profit of $255 million to 31 March 2022, up 13.6% on last year; a record Australian profit; and the delivery of 711 new units and beds (292 in the first half; 419 in the second half). What…
Read more
Over the past year or so, NZSA has been quietly building a closer working relationship with our friends in Australia. We think that’s important – most of us have a more ‘regional’ outlook in our investment approach when investing in this corner of the world. Like others, though, I do wish that most Australians would…
Read more
The key function of any capital market is to raise capital. That is not necessarily well understood by most shareholders as the primary purpose. Indeed, many investors believe that the purpose of a stock market is to facilitate trading and serve the needs of investors. In truth, they are merely ancillary functions that provide credibility…
Read more
On May 16th, we were surprised and saddened to learn of the death of Brian Gaynor earlier that morning. Brian was a staunch supporter of NZSA, with a strong passion for “doing the right thing” for retail shareholders. He was a two-time winner of the Beacon Award (in 2006 and 2020), and shared a passion…
Read more
Asset Plus Limited Special Meeting Report, June 3rd 2022 Click here for NZSA Assessment and Voting intentions A virtual only format was an appropriate vehicle for this 30 minute, single issue special meeting to approve the sale of Asset Plus’s ‘lame duck’ unoccupied Graham Street property. Chair, Bruce Cotterill, and Stephen Brown-Thomas, from external manager…
Read more
“Introduction to Investing” – Waikato Branch Waikato Branch Event, May 31st On May 31st, Waikato Branch ran a repeat of an on-line seminar held earlier in the year. Around 200 people had registered for the presentation, titled “Introduction to Investing”. There were two speakers from Craigs Investment Partners as well as two members of the…
Read more
Neuren Pharmaceuticals Limited Annual Meeting Report, May 30th 2022 Click here for NZSA Assessment and Voting intentions The meeting opened at 2:30pm and was a hybrid meeting. Unfortunately, Neuren did not operate a video presentation so all those online received was an image on the screen and a voice. The chair delivered his address and…
Read more
PharmaZen Limited Annual Meeting Report, May 27th 2022 Click here for NZSA Assessment and Voting intentions Pharmazen Ltd is the parent company of Waitaki Bioscience. PharmaZen has been selling into global markets under the Waitaki brand for over 20 years and considers itself to be an innovative developer, manufacturer and marketer of ‘Science-based natural nutrition’.…
Read more
Vista Group International Limited Annual Meeting Report, May 26th 2022 Click here for NZSA Assessment and Voting intentions This was the first ASM in VGL’s new offices at the ‘City Works Depot’. Full on industrial chic and just the right fit for shareholders and staff who attended. It was also the first time the board…
Read more
Wellington Drive Technology Limited Annual Meeting Report, May 25th 2022 Click here for NZSA Assessment and Voting intentions Despite Covid 19 disruptions, the company had a good year with revenues up 74% to $64.2 million, and EBITDA at $2.6 million. Revenues in North America and Canada were up 41%, Latin America 91%, Europe and Middle…
Read more
